checkAd

    EQS-Adhoc  600  0 Kommentare LifeWatch AG: BioTelemetry, Inc. announces extension of the main offer period for public offer for LifeWatch AG - Seite 4



    It may be difficult for U.S. holders to enforce their rights and any claim arising out of U.S. federal securities laws, since LifeWatch is located in a non-U.S. jurisdiction, and some or all of its officers and directors may be residents of a non-U.S. jurisdiction. U.S. holders may not be able to sue a non-U.S. company or its officers or directors in a non-U.S. court for violations of the U.S. securities laws. Further, it may be difficult to compel a non-U.S. company and its affiliates to subject themselves to a U.S. court's judgment.



    The receipt of cash and stock consideration in the Offer by a U.S. shareholder will generally be a taxable transaction for U.S. federal, state and local income tax purposes. Each U.S. shareholder is urged to consult his independent professional adviser immediately regarding the tax consequences of acceptance of the Offer.



    Securities may not be offered or sold in the U.S. absent registration or an exemption from registration under the U.S. Securities Act. It is expected that the Offer will be subject to a Tier I exemption pursuant to Rule 14d-1(c) of the U.S. Securities Exchange Act of 1934, as amended, and that the issuance of BioTelemetry Common Stock in connection therewith will be exempt from registration under the U.S. Securities Act of 1933, as amended, pursuant to Rule 802 thereof.



    Neither the Securities and Exchange Commission nor any securities commission of any State of the U.S. has (a) approved or disapproved of the Offer, (b) passed upon the merits or fairness of the Offer, or (c) passed upon the adequacy or accuracy of the disclosure in the pre-announcement. Any representation to the contrary is a criminal offense in the U.S.








    Additional features:


    Document: http://n.eqs.com/c/fncls.ssp?u=FSETJGTUAE
    Document title: 20170522_Extension Offer Period_EN

    End of ad hoc announcement






















    Language: English
    Company: LifeWatch AG
    Baarerstrasse 139
    6300 Zug
    Switzerland
    Phone: +41 41 728 67 78
    Internet: www.lifewatch.com
    ISIN: CH0012815459
    Valor: 811189
    Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in Frankfurt; SIX Swiss Exchange





     
    End of Announcement EQS Group News Service



    576305  22-May-2017 CET/CEST




    Seite 4 von 4



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc LifeWatch AG: BioTelemetry, Inc. announces extension of the main offer period for public offer for LifeWatch AG - Seite 4 EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: BioTelemetry, Inc. announces extension of the main offer period for public offer for LifeWatch AG 22-May-2017 / 23:11 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 …